Marketable Securities

6 Months Ended

Jun. 30, 2024

Investments Debt And Equity Securities [Abstract]

Marketable Securities

3.Marketable Securities

The fair value and amortized cost of available-for-sale marketable securities by major security type are presented in the following tables as of the periods presented:

	June 30, 2024
Type of security	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Corporate bonds	$	30,245	$	4	$	(28	)	$	30,221
U.S. government agency securities		12,830		1		(24	)		12,807
U.S. treasury securities		5,647		—		(24	)		5,623
Commercial paper		4,201		—		(3	)		4,198
Asset backed securities		3,693		—		(10	)		3,683
Total marketable securities	$	56,616	$	5	$	(89	)	$	56,532

	December 31, 2023
Type of Security	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Corporate bonds	$	45,686	$	20	$	(53	)	$	45,653
U.S. government agency securities		4,917		9		(5	)		4,921
Total marketable securities	$	50,603	$	29	$	(58	)	$	50,574

The net amortized cost and fair value of available-for-sale marketable securities are presented in the following table as of the periods presented by contractual maturity. Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company may intend to sell a security prior to maturity.

	June 30, 2024
	Amortized Cost		Fair Value
Due to mature:
Less than one year	$	51,333	$	51,265
One year through two years		5,283		5,267
Total	$	56,616	$	56,532

	December 31, 2023
	Amortized Cost		Fair Value
Due to mature:
Less than one year	$	49,651	$	49,618
One year through two years		952		956
Total	$	50,603	$	50,574

During the three and six months ended June 30, 2024 and 2023, there were no realized gains or losses on available-for-sale marketable securities.

As of June 30, 2024 and December 31, 2023, the Company had six and zero securities, respectively, in a continuous unrealized loss position for more than 12 months and considered all such losses to be temporary in nature. The Company reviewed the securities in the tables above and considered the decline in market value for these securities to be primarily attributable to economic and market conditions. As of the periods noted in the tables above, the Company did not intend to sell these securities and did not believe it was more likely than not that it would be required to sell these securities before recovery of their amortized cost basis. Accordingly, the Company did not recognize any credit losses related to its marketable securities in an unrealized loss position during any of the periods noted in the table above.

As of June 30, 2024 and December 31, 2023, accrued interest receivables on the Company’s available-for-sale marketable securities were $478 and $485, respectively, and were included within other current assets as presented on its Condensed Consolidated Balance Sheets.